CHI3L1 and colitis: Phenotypic analyses using CHI3L1 knockout (KO) mice, overexpression models, and anti-CHI3L1 antibody interventions in both acute and chronic inflammatory conditions, such as allergic inflammation, colitis, and pulmonary fibrosis, have yielded critical insights [25,26,27].